Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
152.05
-3.60 (-2.31%)
At close: Oct 8, 2026, 4:00 PM EDT
151.98
-0.07 (-0.05%)
After-hours: Oct 8, 2026, 4:01 PM EDT
Twist Bioscience Market Cap
Twist Bioscience has a market cap or net worth of $9.53 billion as of October 8, 2026. It is the 2,216th most valuable company in the world and the 782nd biggest in the United States. Its market cap has increased by 407.59% in one year.
Market Cap
9.53B
Enterprise Value
9.48B
1-Year Change
407.59%
Global Rank
Country Rank
#782 United States
Category
ChartMarket Cap Chart
Since October 31, 2018, Twist Bioscience's market cap has increased from $372.54M to $9.53B, an increase of 2,459.37%. That is a compound annual growth rate of 50.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 9.53B | 391.57% |
| Dec 31, 2025 | 1.94B | -29.68% |
| Dec 31, 2024 | 2.76B | 29.75% |
| Dec 29, 2023 | 2.13B | 57.83% |
| Dec 30, 2022 | 1.35B | -64.93% |
| Dec 31, 2021 | 3.84B | -43.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bio-Techne | 11.37B |
| Madrigal Pharmaceuticals | 11.27B |
| BioMarin Pharmaceutical | 10.69B |
| ImmunityBio | 10.33B |
| Vaxcyte | 9.96B |
| Krystal Biotech | 9.61B |
| Protagonist Therapeutics | 9.12B |
| Axsome Therapeutics | 9.06B |